NewsSource: EClinCloud

EClinCloud Product Overview | EDC · Electronic Data Capture System for Clinical Trials

3 min readEClinCloud Editorial Team
EClinCloud Product Overview | EDC · Electronic Data Capture System for Clinical Trials header image

Source: EClinCloud. Author: EClinCloud.

EClinCloud · A Clinical Research AI Technology Company

EDC · Electronic Data Capture System for Clinical Trials

AI-Powered Throughout · ALCOA+ Compliance Safeguards

Electronic data capture (EDC) performs the key functions of study data collection, management, and quality control, serving as a core system for ensuring the authenticity, integrity, and traceability of clinical data.

EClinCloud EDC deeply integrates AI capabilities to support intelligent data capture and international regulatory compliance management, helping sponsors build efficient, reliable, and traceable electronic data capture systems.

01 Product Overview

EClinCloud EDC (Electronic Data Capture) combines the strengths of multiple international EDC systems and aligns with both domestic and international user workflows, delivering an integrated solution covering data capture, remote review, and standardized, transparent management; the system offers broad compatibility and robust data integration capabilities, strictly follows ALCOA+ principles, and leverages advanced AI technology to help improve data management efficiency and shorten clinical trial timelines.

02 What We Offer

■ EDC System

■ CRF Design Services

■ Study Database Build Services

■ Data Management and Biostatistics Services

■ System Operation Training and Qualification Certification

■ LLM-Based RAG Parsing and Custom OCR Recognition for Assisted Data Capture

03 AI-Driven Upgrade Across EDC Workflows

AI Agent-Assisted Database Build

The large AI model intelligently interprets study protocols and breaks down operational workflows to configure visits, forms, cross-form links, and edit checks in one workflow, reducing manual omissions and significantly shortening study go-live timelines.

AI + OCR Intelligent Data Capture

Supports intelligent capture of source medical record documents on both PC and mobile apps, synchronizing data to the system in real time while maintaining secure, compliant de-identification of key information and effectively reducing data entry errors.

95% Overall Recognition Rate | 50% Increase in Capture Efficiency | 20% Reduction in SDV Hours

Contact us to learn more about additional AI capabilities...

04 Why Choose EClinCloud EDC

■ AI-Enabled Functional Modules to Accelerate Project Efficiency

■ Data-Driven Design Model to Help Elevate Project Quality

■ Intuitive interface and straightforward configuration effectively lower the learning curve

■ Ensures the security of database change operations is rigorously verified, enhancing data management flexibility and reliability

■ Ensures strict data access control and granular user operation authorization, and provides SOP system certification

05 Value Demonstrated in Client Practice

Case 1: Helping a Leading Pharmaceutical Company Increase Data Entry Efficiency by More Than 2-Fold

EClinCloud AI + OCR recognition intelligently parses paper reports and syncs data directly into EDC, reducing overall entry time per form from 8–10 minutes to under 3 minutes, improving data quality, and lowering project data management labor costs.

Case 2: Providing Digital Support for a National Major Project Study

EClinCloud EDC supports data capture and end-to-end management for a National Science and Technology Major Project study, meeting the needs of multi-center collaborative research and enabling study data standardization, end-to-end quality control, and study process traceability.

Integrated Platform · Interconnected Data

EDCCTMSeTMFeCOARTSMRMIRCeLearningScale ManagementRater Training

📞 Contact Us

Website: www.eclincloud.com

Email: ecc@eclincloud.com

Technological innovation to bring effective treatments to patients




About EClinCloud


EClinCloud is a leading AI company in the clinical research industry, using AI to build an integrated intelligent clinical cloud platform and endpoint assessment technologies. It provides pharmaceutical companies and research institutions worldwide with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services, delivering efficient, accurate digital solutions. Leveraging AI predictive models and an intelligent data platform, EClinCloud dynamically evaluates and helps improve the success rate of drug clinical trials, helping shorten drug/device R&D cycles to benefit patients.







Article illustration

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.